Relevant bibliographies by topics / Mycobacteria

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Mycobacteria'

Author: Grafiati
Published: 4 June 2021
Last updated: 6 September 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Mycobacteria.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Mycobacteria"

1

Harth, Günter, Saša Masleša-Galić, and Marcus A. Horwitz. "A two-plasmid system for stable, selective-pressure-independent expression of multiple extracellular proteins in mycobacteria." Microbiology 150, no. 7 (July 1, 2004): 2143–51. http://dx.doi.org/10.1099/mic.0.27113-0.

Full text
Abstract:
Recombinant mycobacteria expressing Mycobacterium tuberculosis extracellular proteins are leading candidates for new vaccines against tuberculosis and other mycobacterial diseases, and important tools both in antimycobacterial drug development and basic research in mycobacterial pathogenesis. Recombinant mycobacteria that stably overexpress and secrete major extracellular proteins of M. tuberculosis in native form on plasmids pSMT3 and pNBV1 were previously constructed by the authors. To enhance the versatility of this plasmid-based approach for mycobacterial protein expression, the Escherichia coli/mycobacteria shuttle plasmid pGB9 was modified to accommodate mycobacterial genes expressed from their endogenous promoters. Previous studies showed that the modified plasmid, designated pGB9.2, derived from the cryptic Mycobacterium fortuitum plasmid pMF1, was present at a low copy number in both E. coli and mycobacteria, and expression of recombinant M. tuberculosis proteins was found to be at levels paralleling its copy number, that is, approximating their endogenous levels. Plasmid pGB9.2 was compatible with the shuttle vectors pSMT3 and pNBV1 and in combination with them it simultaneously expressed the M. tuberculosis 30 kDa extracellular protein FbpB. Plasmid pGB9.2 was stably maintained in the absence of selective pressure in three mycobacterial species: Mycobacterium bovis BCG, M. tuberculosis and M. smegmatis. Plasmid pGB9.2 was found to be self-transmissible between both fast- and slow-growing mycobacteria, but not from mycobacteria to E. coli or between E. coli strains. The combination of two compatible plasmids in one BCG strain allows expression of recombinant mycobacterial proteins at different levels, a potentially important factor in optimizing vaccine potency.
APA, Harvard, Vancouver, ISO, and other styles
2

Chilima, Benson Z., Ian M. Clark, Sian Floyd, Paul E. M. Fine, and Penny R. Hirsch. "Distribution of Environmental Mycobacteria in Karonga District, Northern Malawi." Applied and Environmental Microbiology 72, no. 4 (April 2006): 2343–50. http://dx.doi.org/10.1128/aem.72.4.2343-2350.2006.

Full text
Abstract:
ABSTRACT The genus Mycobacterium includes many species that are commonly found in the environment (in soil and water or associated with plants and animals), as well as species that are responsible for two major human diseases, tuberculosis (Mycobacterium tuberculosis) and leprosy (Mycobacterium leprae). The distribution of environmental mycobacteria was investigated in the context of a long-term study of leprosy, tuberculosis, Mycobacterium bovis BCG vaccination, and the responses of individuals to various mycobacterial antigens in Karonga District, northern Malawi, where epidemiological studies had indicated previously that people may be exposed to different mycobacterial species in the northern and southern parts of the district. A total of 148 soil samples and 24 water samples were collected from various locations and examined to determine the presence of mycobacteria. The detection method involved semiselective culturing and acid-fast staining, following decontamination of samples to enrich mycobacteria and reduce the numbers of other microorganisms, or PCR with primers specific for the mycobacterial 16S rRNA gene, using DNA extracted directly from soil and water samples. Mycobacteria were detected in the majority of the samples, and subsequent sequence analysis of PCR products amplified directly from soil DNA indicated that most of the products were related to known environmental mycobacteria. For both methods the rates of recovery were consistently higher for dry season samples than for wet season samples. All isolates cultured from soil appeared to be strains of Mycobacterium fortuitum. This study revealed a complex pattern for the environmental mycobacterial flora but identified no clear differences between the northern and southern parts of Karonga District.
APA, Harvard, Vancouver, ISO, and other styles
3

Fol, Marek, Piotr Koziński, Jakub Kulesza, Piotr Białecki, and Magdalena Druszczyńska. "Dual Nature of Relationship between Mycobacteria and Cancer." International Journal of Molecular Sciences 22, no. 15 (August 3, 2021): 8332. http://dx.doi.org/10.3390/ijms22158332.

Full text
Abstract:
Although the therapeutic effect of mycobacteria as antitumor agents has been known for decades, recent epidemiological and experimental studies have revealed that mycobacterium-related chronic inflammation may be a possible mechanism of cancer pathogenesis. Mycobacterium tuberculosis and non-tuberculous Mycobacterium avium complex infections have been implicated as potentially contributing to the etiology of lung cancer, whereas Mycobacterium ulcerans has been correlated with skin carcinogenesis. The risk of tumor development with chronic mycobacterial infections is thought to be a result of many host effector mechanisms acting at different stages of oncogenesis. In this paper, we focus on the nature of the relationship between mycobacteria and cancer, describing the clinical significance of mycobacteria-based cancer therapy as well as epidemiological evidence on the contribution of chronic mycobacterial infections to the increased lung cancer risk.
APA, Harvard, Vancouver, ISO, and other styles
4

Kelley, Victoria A., and Jeffrey S. Schorey. "Mycobacterium's Arrest of Phagosome Maturation in Macrophages Requires Rab5 Activity and Accessibility to Iron." Molecular Biology of the Cell 14, no. 8 (August 2003): 3366–77. http://dx.doi.org/10.1091/mbc.e02-12-0780.

Full text
Abstract:
Many mycobacteria are intramacrophage pathogens that reside within nonacidified phagosomes that fuse with early endosomes but do not mature to phagolysosomes. The mechanism by which mycobacteria block this maturation process remains elusive. To gain insight into whether fusion with early endosomes is required for mycobacteria-mediated inhibition of phagosome maturation, we investigated how perturbing the GTPase cycles of Rab5 and Rab7, GTPases that regulate early and late endosome fusion, respectively, would affect phagosome maturation. Retroviral transduction of the constitutively activated forms of both GTPases into primary murine macrophages had no effect on Mycobacterium avium retention in an early endosomal compartment. Interestingly, expression of dominant negative Rab5, Rab5(S34N), but not dominant negative Rab7, resulted in a significant increase in colocalization of M. avium with markers of late endosomes/lysosomes and increased mycobacterial killing. This colocalization was specific to mycobacteria since Rab5(S34N) expressing cells showed diminished trafficking of endocytic tracers to lysosomes. We further demonstrated that maturation of M. avium phagosomes was halted in Rab5(S34N) expressing macrophages supplemented with exogenous iron. These findings suggest that fusion with early endosomes is required for mycobacterial retention in early phagosomal compartments and that an inadequate supply of iron is one factor in mycobacteria's inability to prevent the normal maturation process in Rab5(S34N)-expressing macrophages.
APA, Harvard, Vancouver, ISO, and other styles
5

Cayer, Marie-Pierre, Marc Veillette, Pascal Pageau, Richard Hamelin, Marie-Josée Bergeron, Anne Mériaux, Yvon Cormier, and Caroline Duchaine. "Identification of mycobacteria in peat moss processing plants: application of molecular biology approaches." Canadian Journal of Microbiology 53, no. 1 (January 1, 2007): 92–99. http://dx.doi.org/10.1139/w06-105.

Full text
Abstract:
Peat moss processing plant workers are exposed to high concentrations of bioaerosols. Although mycobacteria have been cultured from peat moss, no study has examined the workers' exposure to mycobacterial bioaerosols. We evaluated the presence of mycobacteria in air samples from peat moss processing plants using molecular biology approaches (cloning-sequencing and polymerase chain reaction (PCR)) and the workers exposure using immunoglobulin G (IgG) complexes to mycobacteria. In addition, species detected in air samples and in peat moss were compared. Two peat moss processing plants were chosen among 14 previously studied. A total of 49 clones were sequenced. Real-time PCR was also performed on the same air samples to evaluate the airborne concentration of mycobacteria and estimate exposure levels. Several Mycobacterium species were present in the air samples (M. malmoense, M. smegmatis, M. graceum, M. bohemicum, and M. interjectum). Mycobacterium avium was recovered by culture in peat moss but not in the air using the molecular approach. Total airborne Mycobacterium concentration was estimated at 8.2 × 108/m3. Workers had IgG against the mycobacterial mix and M. avium, suggesting significant exposure. The findings from air samples, supported by IgG measurements, demonstrate that peat moss processing plant workers are exposed to mycobacteria in addition to other biological agents.Key words: exposure, peat moss, airborne mycobacteria.
APA, Harvard, Vancouver, ISO, and other styles
6

Mah, Nancy, Carolina Perez-Iratxeta, and Miguel A. Andrade-Navarro. "Outer membrane pore protein prediction in mycobacteria using genomic comparison." Microbiology 156, no. 8 (August 1, 2010): 2506–15. http://dx.doi.org/10.1099/mic.0.040089-0.

Full text
Abstract:
Proteins responsible for outer membrane transport across the unique membrane structure of Mycobacterium spp. are attractive drug targets in the treatment of human diseases caused by the mycobacterial pathogens, Mycobacterium tuberculosis, M. bovis, M. leprae and M. ulcerans. In contrast with Escherichia coli, relatively few outer-membrane proteins (OMPs) have been identified in Mycobacterium spp., largely due to the difficulties in isolating mycobacterial membrane proteins and our incomplete understanding of secretion mechanisms and cell wall structure in these organisms. To further expand our knowledge of these elusive proteins in mycobacteria, we have improved upon our previous method of OMP prediction in mycobacteria by taking advantage of genomic data from seven mycobacteria species. Our improved algorithm suggests 4333 sequences as putative OMPs in seven species with varying degrees of confidence. The most virulent pathogenic mycobacterial species are slightly enriched in these selected sequences. We present examples of predicted OMPs involved in horizontal transfer and paralogy expansion. Analysis of local secondary structure content allowed identification of small domains predicted to perform as OMPs; some examples show their involvement in events of tandem duplication and domain rearrangements. We discuss the taxonomic distribution of these discovered families and architectures, often specific to mycobacteria or the wider taxonomic class of Actinobacteria. Our results suggest that OMP functionality in mycobacteria is richer than expected and provide a resource to guide future research of these understudied proteins.
APA, Harvard, Vancouver, ISO, and other styles
7

Durnez, Lies, Miriam Eddyani, Georgies F. Mgode, Abdul Katakweba, Charles R. Katholi, Robert R. Machang'u, Rudovik R. Kazwala, Françoise Portaels, and Herwig Leirs. "First Detection of Mycobacteria in African Rodents and Insectivores, Using Stratified Pool Screening." Applied and Environmental Microbiology 74, no. 3 (December 7, 2007): 768–73. http://dx.doi.org/10.1128/aem.01193-07.

Full text
Abstract:
ABSTRACT With the rising number of patients with human immunodeficiency virus (HIV)/AIDS in developing countries, the control of mycobacteria is of growing importance. Previous studies have shown that rodents and insectivores are carriers of mycobacteria. However, it is not clear how widespread mycobacteria are in these animals and what their role is in spreading them. Therefore, the prevalence of mycobacteria in rodents and insectivores was studied in and around Morogoro, Tanzania. Live rodents were trapped, with three types of live traps, in three habitats. Pieces of organs were pooled per habitat, species, and organ type (stratified pooling); these sample pools were examined for the presence of mycobacteria by PCR, microscopy, and culture methods. The mycobacterial isolates were identified using phenotypic techniques and sequencing. In total, 708 small mammals were collected, 31 of which were shrews. By pool prevalence estimation, 2.65% of the animals were carriers of mycobacteria, with a higher prevalence in the urban areas and in Cricetomys gambianus and the insectivore Crocidura hirta. Nontuberculous mycobacteria (Mycobacterium chimaera, M. intracellulare, M. arupense, M. parascrofulaceum, and Mycobacterium spp.) were isolated from C. gambianus, Mastomys natalensis, and C. hirta. This study is the first to report findings of mycobacteria in African rodents and insectivores and the first in mycobacterial ecology to estimate the prevalence of mycobacteria after stratified pool screening. The fact that small mammals in urban areas carry more mycobacteria than those in the fields and that potentially pathogenic mycobacteria were isolated identifies a risk for other animals and humans, especially HIV/AIDS patients, that have a weakened immune system.
APA, Harvard, Vancouver, ISO, and other styles
8

Zavgorodniy, A. I., S. A. Pozmogova, and M. V. Kalashnyk. "Domestic parrots as a potential source of Mycobacteriosis." Journal for Veterinary Medicine, Biotechnology and Biosafety 6, no. 2 (February 28, 2020): 5–8. http://dx.doi.org/10.36016/jvmbbs-2020-6-2-1.

Full text
Abstract:
The article presents the results of bacteriological examination of five samples of feces from grey parrots (Psittacus) (n = 3), cockatoo (Cacatua) (n = 1), yellow-crowned amazon (Amazona) (n = 1). Five cultures of mycobacteria were bacteriologically isolated from the five samples. According to biochemical and cultural-morphological characteristics, mycobacterial cultures are classified as Mycobacterium scrofulaceum (n = 1) and Mycobacterium genavense (n = 4). Isolated cultures of mycobacteria are important in human pathology. Infected exotic poultry pose a potential risk of mycobacterial infection in their owners, so it is necessary to conduct research on biological material
APA, Harvard, Vancouver, ISO, and other styles
9

Chin, Kai Ling. "Molecular Characterization of Mycobacterium species Isolates from Patients with Pulmonary Tuberculosis in Sabah, Malaysia." Medicine & Health 17, no. 1 (June 29, 2022): 198–210. http://dx.doi.org/10.17576/mh.2022.1701.15.

Full text
Abstract:
Tuberculosis (TB) is one of the deadliest diseases worldwide, caused by members of Mycobacterium tuberculosis complex (MTBC), commonly by Mycobacterium tuberculosis (Mtb) and Mycobacterium bovis. In Malaysia, Sabah is one of the states of public health concern with the highest TB cases. Clinical presentations of TB and non-tuberculous mycobacteria (NTM) lung disease are similar, and mycobacteria appear to be identical under standard diagnosis with sputum smear microscopy, causing difficulty to diagnose TB. Identification of Mycobacterium species is essential for effective management of mycobacterial diseases treatment and their control strategy. Thus, this study aimed to identify the Mycobacterium species from suspected TB patients in Sabah using molecular methods. Sputum samples (n=595) were screened with GeneXpert MTB/RIF (Xpert), and positive TB samples (n=67) were processed and cultured in BACTEC MGIT. Forty-five isolates were successfully recovered in MGIT and characterisation of the mycobacterial isolates using PCR and/or sequencing with rpoB, RD9, hsp65, and 16S rRNA genes confirmed the presence of Mtb in 41 samples, and four non-mycobacteria, i.e. Microbacterium laevaniformans, Streptomyces sp., Streptomyces misionensis and Gordonia sp. These non-mycobacteria isolates showed negative results when tested directly with Xpert. In conclusion, Mtb is the predominant species of MTBC circulating in Sabah. The presence of non-mycobacteria in this study was due to bacterial contamination in MGIT, not bacterial cross-reactivity in Xpert, implying the high sensitivity and specificity of Xpert for diagnosis of TB.
APA, Harvard, Vancouver, ISO, and other styles
10

Le Dantec, Corinne, Jean-Pierre Duguet, Antoine Montiel, Nadine Dumoutier, Sylvie Dubrou, and Véronique Vincent. "Occurrence of Mycobacteria in Water Treatment Lines and in Water Distribution Systems." Applied and Environmental Microbiology 68, no. 11 (November 2002): 5318–25. http://dx.doi.org/10.1128/aem.68.11.5318-5325.2002.

Full text
Abstract:
ABSTRACT The frequency of recovery of atypical mycobacteria was estimated in two treatment plants providing drinking water to Paris, France, at some intermediate stages of treatment. The two plants use two different filtration processes, rapid and slow sand filtration. Our results suggest that slow sand filtration is more efficient for removing mycobacteria than rapid sand filtration. In addition, our results show that mycobacteria can colonize and grow on granular activated carbon and are able to enter distribution systems. We also investigated the frequency of recovery of mycobacteria in the water distribution system of Paris (outside buildings). The mycobacterial species isolated from the Paris drinking water distribution system are different from those isolated from the water leaving the treatment plants. Saprophytic mycobacteria (present in 41.3% of positive samples), potentially pathogenic mycobacteria (16.3%), and unidentifiable mycobacteria (54.8%) were isolated from 12 sites within the Paris water distribution system. Mycobacterium gordonae was preferentially recovered from treated surface water, whereas Mycobacterium nonchromogenicum was preferentially recovered from groundwater. No significant correlations were found among the presence of mycobacteria, the origin of water, and water temperature.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Mycobacteria"

1

Nakedi, Kehilwe Confidence. "Comprehensive definition of Ser/Thr/Tyr phosphorylation in mycobacteria: towards understanding reprogramming of normal macrophage function by pathogenic mycobacteria." Doctoral thesis, University of Cape Town, 2018. http://hdl.handle.net/11427/29707.

Full text
Abstract:
Mycobacterium tuberculosis, the causative agent for the disease Tuberculosis, is a serious public health problem that is responsible for 1.6 million deaths each year. The WHO’s recent report on Tuberculosis estimates that a third of the world’s population is latently infected with the bacteria, and, of those, 10% will progress to active disease. M. tuberculosis is a successful pathogen mainly due to its ability to adapt and survive in changing environments. It can survive a dormant state with limited metabolic activity during latent infection, while also being able to escape the macrophage and disseminate into active disease. Efforts to eradicate the disease must be based on understanding the biology of this organism, and the mechanisms it uses to infect, colonize, and evade the immune system. Understanding the behaviour of pathogenic mycobacteria in the macrophage is also important to the discovery of new drug targets. In this thesis, we employed state of the art mass spectrometry techniques, which allowed us to unpack the biology of this bacterium in different growth environments and expand our understanding of the mechanisms it employs to adapt and survive. We investigated protein regulation by the process of phosphorylation, through sensory kinases, which add a phosphate group to a protein of interest, thereby regulating its function. First, we interrogated the phosphoproteomic landscape between M. bovis BCG and M. smegmatis to explain how differential protein regulation results in the differences between slow and fast growth of mycobacteria. Second, we focused on Protein Kinase G (PknG), which plays an important role in bacterial survival by blocking phagosome/lysosome fusion. We identified the in vivo physiological substrates of this kinase in actively growing M.bovis BCG culture. Our results revealed that this kinase is a regulator of protein synthesis. We then examined the mechanisms of survival in murine RAW 246.7 macrophages mediated by PknG, using M. bovis BCG reference strain and PknG knock-out mutant. Our results indicated strong evidence that pathogenic mycobacteria disrupt the macrophagic cytoskeleton, through phosphorylation of proteins that are involved in cytoskeleton rearrangement. These results explain the strategies that pathogenic mycobacteria employ mediated by PknG to block phagosome-lysosome fusion and evade the host immune system and survive for prolonged periods in the macrophages. The findings of this thesis contribute to our understanding of the physiology of pathogenic mycobacteria and their interaction with the host.
APA, Harvard, Vancouver, ISO, and other styles
2

Hasan, Zehra. "Mycobacterium - host interactions : trafficking of mycobacteria within the host cell." Thesis, Imperial College London, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.264976.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Millar, Douglas Spencer. "Mycobacterium paratuberculosis, mycobacteria and chronic enteritis in humans and animals." Thesis, St George's, University of London, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.308932.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Muhammed, Ameen Sirwan. "Re-evaluation of older antibiotics in the area of resistant mycobacteria." Thesis, Aix-Marseille, 2013. http://www.theses.fr/2013AIXM5058.

Full text
Abstract:
Chez les patients traités par un régime posologique, La concentration sérique moyenne et l'écart type de la concentration SMX était 161,01 ± 69,154 mg/L et de 5,788 ± 2,74 mg/L pour le TMP. La concentration minimale inhibitrice 90% (CMI 90) était de 10 mg/L pour le cotrimoxazole et la sulfadiazine contre Mycobacterium tuberculosis. Toutes les mycobactéries étaient inhibées par 20 mg/L de cotrimoxazole et de sulfadiazine. Les CMI de l'ivermectine contre 13 souches complexe M. tuberculosis ont varié entre 10 et 40 mg/L. En outre, tous isoler M. tuberculosis étaient résistants à la squalamine avec CMI > 100 mg/L. Dans une autre partie nous avons montré que tous les isolats du complexe Mycobacterium avium étaient résistants au triméthoprime avec une CMI > 200 mg/mL. Le cotrimoxazole, le sulfaméthoxazole et la sulfadiazine ont montré une CMI respectivement de 10 mg/L, 25 mg/L et 20 mg/L, à l'exception de Mycobacterium chimaera qui présentait une CMI de 10 mg/L pour ces molécules. La comparaison de la séquence du gène de la dihydroptéroate synthase de M. intracellulare et M. chimaera a montré seulement quatre changements d'acides aminés
Firstly, we measured the serum concentration of Sulfamethoxazole (SMX)-Trimethoprim (TMP) in patients treated with high dosage regimen. The mean values and standard deviation for SMX concentration was 161.01± 69.154 mg/L and of 5.788 ± 2.74 mg/L for TMP. Susceptibility testing yielded a minimum inhibitory concentration 90% (MIC90) of 10 mg/L for cotrimoxazole and sulfadiazine. All M. tuberculosis complex mycobacteria (MTC) were inhibited by 20 mg/L cotrimoxazole and sulfadiazine. Also, the MICs of ivermectin varied between 10 and 40 mg/L, against 13 MTC mycobacteria. Moreover, all M. tuberculosis isolate were resistant to squalamine with MIC > 100 mg/L. Also, all Mycobacterium avium complex (MAC) isolates were resistant to trimethoprim with MIC > 200 mg/L. Cotrimoxazole, sulfamethoxazole and sulfadiazine exhibited MIC of 10 mg/L, 25 mg/L and 20 mg/L, respectively against all tested MAC isolates except for Mycobacterium chimaera which exhibited MICs of 10 mg/L for these molecules. Comparing the DHPS gene sequence in M. intracellulare and M. chimaera type strains and clinical isolates yielded only four amino acid changes
APA, Harvard, Vancouver, ISO, and other styles
5

Coulombe, François. "NOD2 and Mycobacteria." Thesis, McGill University, 2010. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=86837.

Full text
Abstract:
The genus Mycobacterium comprises a variety of highly successful intracellular pathogens. Mycobacterium tuberculosis is the causative agent of tuberculosis (TB) in humans and currently infects one third of the world's population. Mycobacterium avium ssp. paratuberculosis is the established cause of Johne's disease in ruminants and is epidemiologically associated with Crohn's disease (CD) in humans. Both TB and CD are complex genetic diseases for which immunological pathways associated with disease susceptibility or resistance have been identified based on human genetic studies. Common polymorphisms in NOD2 have recently been described to predispose to CD. NOD2 encodes a receptor of the Nod-like receptor (NLR) family involved in mediating innate immunity upon recognition of fragments of bacterial peptidoglycan (PGN), a structural component of most bacterial cell wall. CD-associated NOD2 polymorphisms were shown to abrogate this response. While recent studies have uncovered an important role of NOD2 for the recognition of mycobacterial species, the consequences and significance of this recognition remain obscure. The first part of the work presented in this thesis investigates the consequences of NOD2-mediated recognition on innate responses, adaptive immunity and resistance to mycobacterial infection. Using Nod2-deficient mice as a model to study CD-associated NOD2 mutations in humans, we show that the NOD2 pathway is critical for both innate and acquired anti-mycobacterial immunity. Impaired mycobacterial recognition at early time points following infection altered the immunopathology in the lungs and resulted in decreased survival of Nod2-deficient mice when virulent M. tuberculosis was given by aerosol. The second part of this thesis focuses on the biochemical basis of mycobacterial recognition by NOD2. The bacterial N-acetylmuramic acid hydroxylase (NamH) enzyme introduces a specific modification in PGN. We correlated the presence of this enzyme in mycobacteri
Le genus Mycobacterium comprend une variété de bactéries pathogènes intracellulaires. Mycobacterium tuberculosis cause la tuberculose (TB) chez les humains et infecte présentement près d'un tier de la population mondiale. Mycobacterium avium ssp. paratuberculosis cause la maladie de Johne chez les ruminants et est associé à la maladie de Crohn chez les humains. La TB et la maladie de Crohn sont toutes deux des maladies génétiques complexes pour lesquelles des aspects clés de la réponse immunitaire associés à la résistance ou à la susceptibilité à la maladie ont émergés d'études génétiques humaines. Il a récemment été démontré que des polymorphismes communs dans le gène NOD2 prédisposaient à la maladie de Crohn. NOD2 encode un récepteur de la famille des Nod-like receptor (NLR) impliqué dans la réponse immunitaire innée lors de la détection de fragments de peptidoglycan (PGN) bactérien, une composante structurelle de la membrane de la plupart des bactéries. De plus, il a été démontré que les polymorphismes de NOD2 associés à la maladie de Crohn empêchaient cette réponse. Bien que certaines études récentes rapportent un rôle important de NOD2 pour la détection d'espèces mycobactériennes, les conséquences et les raisons associées à cette détection demeurent obscures. La première partie du travail présenté dans cette thèse explore les conséquences du rôle de NOD2 sur la réponse immunitaire innée, la réponse immunitaire adaptative et la résistance à une infection mycobacterienne. Des souris déficientes du gène Nod2 sont utilisées comme modèle d'étude des mutations de NOD2 associées à la maladie de Crohn's. À l'aide de ces souris, nous démontrons que la voie de signalisation NOD2 est critique pour la réponse immunitaire anti-mycobactérienne à la fois innée et adaptative. Un défaut de détection mycobactérienne dans les semaines suivant l'infection a mené à une altération de l'immunopat
APA, Harvard, Vancouver, ISO, and other styles
6

Jönsson, Bodil. "Epidemiological and immunological studies of environmental mycobacteria : with focus on Mycobacterium abscessus /." Göteborg : Clinical Bacteriology Section, Dept of Infectious medicine, Sahlgrenska Academy, University of Gothenburg, 2009. http://hdl.handle.net/2077/19060.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hoza, Abubakar Shaaban. "Molecular characterization of Mycobacterium tuberculosis complex and prevalence of nontuberculous mycobacteria and other potential pathogenic bacteria from Tubercolisis suspents in Northeastern, Tanzania." Doctoral thesis, Universitätsbibliothek Leipzig, 2016. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-211093.

Full text
Abstract:
Molecular typing is increasingly essential to tuberculosis (TB) control programmes, providing public health practitioners with a tool to characterize transmission patterns, track the emergence and spread of strains of M. tuberculosis complex (MTC) in populations. While molecular typing is already used extensively as a tool for TB control in many developed settings across the globe, its use in resource-poor settings is still limited. Moreover, information on the role, contribution and burden of nontuberculous mycobacteria (NTM) and other pathogens in aetiology of TB-like syndromes is also lacking in such settings. The broad objective of this dissertation was to determine the genetic diversity of MTC and their drug resistance profiles as well as the prevalence of NTM and other potentially pathogenic bacteria among TB suspects in Northeastern, Tanzania in order to generate insights that may inform the design of a rational TB control programmes. A total of 18 distinct spoligotypes were identified in this study area, with CAS1-KILI and EAI8 being the most predominant families. Major lineages prediction by conformal Bayesian network (CBN) revealed that 70% of TB infections in this area is due to modern lineages, whereas 30% of TB infections is due to the ancestral lineages mainly of Indo-oceanic lineage. The study also revealed that the overall proportions of any drug resistance and MDR-TB were 12.7% and 6.3% respectively. With the prevalence of any drug resistance and MDR-TB among new cases being 11.4% and 4.3% respectively, among previously, treated cases were 22.2%. The prevalence of NTM was found to be 9.7 %, with HIV being a significant predictor of NTM detection (P < 0.001). Four out of 30 patients with NTM diagnosed by culture received 1st line anti-TB treatment suggesting that a proportion of patients diagnosed by smear microscopy (4/65, 6.2%) were mistreated as TB patients. Our findings further showed that 17 (4.6%) out of 372 TB suspects were due to pulmonary nocardiosis. Overall this dissertation has revealed that TB is still a major problem in Tanga and is characterized by a diverse array of MTB strains. Additionally, modern MTB strains contribute significantly to TB infections in this area. High proportions of anti-TB drug resistance among new treated cases observed suggest that more efforts need to be done to identify individual cases at facility level for improved TB control programmes. Inefficient screening of TB patients and a prevalent increase of NTM may contribute to both unrealistic and mismanagement of TB cases. A diverse array of pathogenic Nocardia species among TB suspects further indicates that they are likely cause of human disease in this population. Therefore, need to integrate NTM and pathogens causing TB-like syndromes in diagnosis and management of TB is urgent. Results of these investigations contribute to the understanding of the dynamics of TB transmission in resource poor settings of Tanzania and highlight key factors that should be considered in the development of rational approaches to design effective TB prevention and control programmes in the country.
APA, Harvard, Vancouver, ISO, and other styles
8

Linde, Charlotte M. A. "Defense peptides against Mycobacteria /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-480-5/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sherratt, Anna Louise. "Lipid bodies in mycobacteria." Thesis, University of Leicester, 2008. http://hdl.handle.net/2381/30499.

Full text
Abstract:
A survey of clinical samples revealed that LBs are a universal feature of tubercle bacilli in sputum. A number of conditions including hypoxia, Nitric Oxide (NO) exposure, pH, heat and cold shock were shown to promote LB formation in M. tuberculosis in vitro. The formation of LBs in NO exposed M. tuberculosis was shown to correlate with the level of antibiotic tolerance displayed by the population. Antibiotic tolerance was thought to be a result of transitory growth arrest; however attempts to assess the growth status of LB positive M. tuberculosis cells were unsuccessful. The morphology of LBs in mycobacteria varied according to the growth condition of the cell and may be due to a change in lipid composition. The mechanism by which LBs are formed in mycobacteria remains unknown; however, there was some evidence to suggest that it follows a scheme similar to that which has been previously demonstrated in Rhodococcus opacus. It was concluded that LB formation in mycobacteria may depend on a number of environmental factors, including conditions that promote growth arrest. The formation of LBs in M. tuberculosis may anticipate antibiotic tolerance. The presence of LBs in sputum tubercle bacilli may be used to assess treatment response in patients with tuberculosis; however, it remains to be shown that LB positive M. tuberculosis cells in vitro represent the physiological LB positive sputum bacilli.
APA, Harvard, Vancouver, ISO, and other styles
10

Mathie, Heather. "Early macrophage response to Mycobacterium avium subspecies paratuberculosis." Thesis, University of Edinburgh, 2018. http://hdl.handle.net/1842/31378.

Full text
Abstract:
Mycobacterium avium subsp. paratuberculosis (MAP) is the causative agent of Johne's disease, a chronic enteritis that has a damaging economic and welfare impact on the livestock industry. Johne's disease in cattle is known to reduce milk yield and carcass value, making it of economic concern to both dairy and beef farmers. In addition, there is cause for concern regarding zoonotic transmission, as there is an unconfirmed but potential relationship between MAP infection and human Crohn's disease, which presents similar clinical symptoms. MAP is most often contracted by neonates through the faecal-oral route, but can also be spread through contact with contaminated milk and colostrum, as well as in utero. Once the host receives an oral dose, the bacteria traverse the gut epithelium and are phagocytosed by gut macrophages residing in the lamina propria and Peyer's patches. MAP are able to evade the macrophage response by resisting intracellular degradation within phagosomes. Infected macrophages respond to the infection by secreting several pro-inflammatory cytokines that drive the downstream immune response and granuloma formation. This work aimed to elucidate key early responses of bovine monocyte derived macrophages (MDM) to MAP infection, and determine the reliability of using the reference strain, K10 (which is likely to have undergone lab adaptation) to model the infection in vitro, by comparing the MDM response to K10 with the response to a recent clinical isolate, C49. At a multiplicity of infection of 5 (MOI 5), there was a significant decrease in K10 intracellular survival (~90%), compared to C49 intracellular survival, over a 24 hour infection time-course. This suggests that K10 may have lost some virulence mechanism through lab adaptation. Understanding the mechanisms of how MDM respond to these two strains could be informative for the design of targeted vaccines When further investigating the MDM response to both strains, it was found that, at MOI 5, MDM infected with K10 secreted higher levels of IL-1β and IL-10, compared to MDM infected with C49. Both cytokines are associated with mycobacterial infection and could perhaps indicate that MDM are more responsive to the K10 strain at early time-points. In addition, MDM infected with K10 produced significantly higher levels of reactive nitrogen species (RNS). RNS are antimicrobial products that can destroy invading pathogens, and have been shown to have bactericidal effects on MAP. The production of RNS could, therefore be a potential mechanism by which MDM are able to kill K10 more efficiently than C49. An additional aim of this project was to understand the importance of the route of phagocytosis in determining the outcome of MAP infection. MDM express several phagocytic receptors, including Fc receptors (FcRs), complement receptors (CR), Ctype lectin receptors and scavenger receptors. This project mainly focused on the role of the mannose receptor (MR) on bacterial uptake and downstream immune responses, as past studies have suggested that other species of mycobacteria such as M. tuberculosis, target the mannose receptor in order to regulate macrophage immune responses. Blocking the MR reduced intracellular survival for both strains of MAP; however, the mechanism by which the MR influences intracellular survival remains poorly understood The effect of opsonisation on MAP prior to uptake by phagocytic cells was also investigated, as presence of opsonins, such a complement proteins and antibody, can change the mechanism by which pathogens are phagocytosed. MAP were incubated in serum from either MAP- negative or MAP- positive cattle, prior to infection and the percentage uptake and survival assessed by performing colony counts. Opsonisation in serum from Johne's negative cattle resulted in marked increase in MAP uptake but not intracellular survival, whereas opsonisation in serum from Johne's positive cattle did not increase uptake but decreased the intracellular survival rate by 24 HPI. This finding highlights a potential protective role of antibody early in the infection process, and could significantly impact how the infection is modelled in future, as anti-MAP antibody may be present in contaminated milk at the point of infection. Taken together, the data presented in this thesis show that bacterial strain has a significant impact on MDM response to MAP infection, which may have important implications for the interpretation of previous studies and the design of future studies investigating host-pathogen interactions in the context of paratuberculosis. Additionally, this work has shown that RNS production and the mechanism of uptake can affect intracellular survival rates, and although this needs further investigation, the findings could have implications for the design of future vaccines.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Mycobacteria"

1

Manuel, Casal, ed. Mycobacteria of clinical interest: Proceedings of the International Symposium on Mycobacteria of Clinical Interest, Cordoba, Spain, 27-28 September 1985. Amsterdam: Excerpta Medica, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

R, Gangadharam P., ed. Mycobacteria. [S.l.]: Chapman and Hall, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gangadharam, Pattisapu R. J., and P. Anthony Jenkins, eds. Mycobacteria. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-7511-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ratledge, Colin, and Jeremy Dale, eds. Mycobacteria. Oxford, UK: Blackwell Publishing Ltd., 1999. http://dx.doi.org/10.1002/9781444311433.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gangadharam, Pattisapu R. J., and P. Anthony Jenkins, eds. Mycobacteria. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5987-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

J, Gangadharam Pattisapu R., and Jenkins P. Anthony, eds. Mycobacteria. New York: Chapman & Hall, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gangadharam, Pattisapu Rama Jogi, 1930- and Jenkins P. A, eds. Mycobacteria. New York: Chapman & Hall, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

The ecology of mycobacteria. Dordrecht: Kluwer Academic, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Parish, Tanya, and Neil G. Stoker. Mycobacteria Protocols. New Jersey: Humana Press, 1998. http://dx.doi.org/10.1385/0896034712.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Parish, Tanya, and Anuradha Kumar, eds. Mycobacteria Protocols. New York, NY: Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-1460-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Mycobacteria"

1

Goodfellow, Michael, and John G. Magee. "Taxonomy of Mycobacteria." In Mycobacteria, 1–71. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5987-0_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Collins, Frank M. "Animal Models for Tuberculosis Research." In Mycobacteria, 292–307. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5987-0_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Heifets, L. B., and P. A. Jenkins. "Speciation of Mycobacteria in Clinical Laboratories." In Mycobacteria, 308–50. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5987-0_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

de Kantor, Isabel N., and Adalbert Laszlo. "Tuberculosis Laboratory Procedures for Developing Countries." In Mycobacteria, 351–90. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5987-0_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gangadharam, Pattisapu R. J. "Drug Resistance in Tubercle Bacilli." In Mycobacteria, 72–101. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5987-0_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Shinnick, Thomas M. "Molecular Biology of Mycobacterium Tuberculosis." In Mycobacteria, 102–30. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5987-0_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Crawford, Jack T. "Molecular Approaches to the Detection of Mycobacteria." In Mycobacteria, 131–44. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5987-0_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Grange, John M. "Pathogenesis of Mycobacterial Disease." In Mycobacteria, 145–77. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5987-0_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Falkinham, Joseph O. "Transmission of Mycobacteria." In Mycobacteria, 178–209. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5987-0_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jarvis, William R. "Nosocomial Mycobacterium Tuberculosis Outbreaks: Risk Factors, Prevention Intervention Efficacy, and Guidelines." In Mycobacteria, 210–34. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5987-0_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Mycobacteria"

1

Pedrero Tejada, Sandra, Eva Tabernero Huguet, Borja Ortiz De Urbina Antia, Idoia Salinas Garrido, Beatriz Gonzalez Quero, Eunate Arana Arri, Elena Urra Zalbidegoitia, and Rafael Zalacain Jorge. "MYCOBACTERIUM KANSASII LUNG INFECTIONS COMPARED TO OTHER NONTUBERCULOUS MYCOBACTERIA." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa4718.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Nishio, C., H. Konishi, T. Ochi, K. Oh, and H. Tomioka. "Clinical Significance of Isolation of Mycobacterium Tuberculosis Among Patients with Non-Tuberculous Mycobacteria." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5179.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Branagan, Peter, Benvon Moran, Margaret Fitzgibbon, Valerie Reid, Mairin McMenamin, Maria Kane, Fiona Kelly, Louise Barnes, Annemarie McLaughlin, and Joseph M. Keane. "A Tale Of Two Mycobacteria." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2331.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Conceição, Mariana, Ângela Dias Cunha, Rita Ferro, Sónia Guerra, Joana Batista Correia, António Reis, and António Simões Torres. "Non-tuberculous mycobacteria: five year experience." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.3342.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dymova, Maya, Olga Alkhovik, Lubov Evdokimova, Andrey Cherednichenko, Tatjana Petrenko, and Yana Batyrshina. "Whole genome-sequencing of non-tuberculous mycobacteria." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa891.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Shah, Neeraj, Akanksha Malhotra, Felicity Perrin, Marc Lipman, George Santis, and Ronan Breen. "Mediastinal nontuberculous mycobacteria (NTM) – A rare entity." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa2681.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Alkhovik, Olga, Tatiana Petrenko, and Ivan Meshkov. "Drug resistance of Nontuberculous mycobacteria in Siberia." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa3636.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Jampilek, Josef, and Martin Pisarcik. "Impact of Nanoparticles on Bacteria and Mycobacteria." In The 6th World Congress on Recent Advances in Nanotechnology. Avestia Publishing, 2021. http://dx.doi.org/10.11159/nddte21.lx.201.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Barca Hernando, Maria, Juan Francisco Medina Gallardo, Verónica González-Galán, Ana Rodriguez-Rey, Rafael Luque Márquez, and Javier Aznar Martín. "Isolation of Nontuberculous Mycobacteria in Seville, Spain." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.2373.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Shu, C., P. Wang, and C. Chang. "The impact of nontuberculous mycobacteria species on non-cancer mortality in patients with nontuberculous mycobacterial lung disease." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.543.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Mycobacteria"

1

Lollis, Blake D., and Robert S. Kent. Cluster of Nontuberculous Mycobacteria Skin Infections from Tattoos. Fort Belvoir, VA: Defense Technical Information Center, July 2010. http://dx.doi.org/10.21236/ada523390.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fritzinger, David C. Rapid Detection of Mycobacteria in Patients with HIV Infection. Fort Belvoir, VA: Defense Technical Information Center, May 1994. http://dx.doi.org/10.21236/ada281636.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Patel, Rubina J. Rapid Detection of Mycobacteria in Patients with HIV Infection. Fort Belvoir, VA: Defense Technical Information Center, June 1992. http://dx.doi.org/10.21236/ada255253.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fritzinger, David C. Rapid Detection of Mycobacteria in Patients with HIV Infection. Fort Belvoir, VA: Defense Technical Information Center, May 1993. http://dx.doi.org/10.21236/ada265567.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nelson, Corwin D., Donald C. Beitz, Timothy A. Reinhardt, and John D. Lippolis. Regulation of Immune Responses to Mycobacteria bovis by a Paracrine Mechanism of Vitamin D Signaling in Cattle. Ames (Iowa): Iowa State University, January 2011. http://dx.doi.org/10.31274/ans_air-180814-646.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Yu, Guocan, Yanqin Shen, Xudong Xu, and Lihua Lin. Nucleic acid amplification techniques for rapid diagnosis of non-tuberculous mycobacteria: A protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2020. http://dx.doi.org/10.37766/inplasy2020.11.0076.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bercovier, Herve, Raul Barletta, and Shlomo Sela. Characterization and Immunogenicity of Mycobacterium paratuberculosis Secreted and Cellular Proteins. United States Department of Agriculture, January 1996. http://dx.doi.org/10.32747/1996.7573078.bard.

Full text
Abstract:
Our long-term goal is to develop an efficient acellular vaccine against paratuberculosis based on protein antigen(s). A prerequisite to achieve this goal is to analyze and characterize Mycobacterium paratuberculosis (Mpt) secreted and cellular proteins eliciting a protective immune response. In the context of this general objective, we proposed to identify, clone, produce, and characterize: the Mpt 85B antigen and other Mpt immunoreactive secreted proteins, the Mpt L7/L12 ribosomal protein and other immunoreactive cellular proteins, Mpt protein determinants involved in invasion of epithelial cells, and Mpt protein antigens specifically expressed in macrophages. Paratuberculosis is still a very serious problem in Israel and in the USA. In the USA, a recent survey evaluated that 21.6% of the dairy herd were infected with Mpt resulting in 200-250 million dollars in annual losses. Very little is known on the virulence factors and on protective antigens of Mpt. At present, the only means of controlling this disease are culling or vaccination. The current vaccines do not allow a clear differentiation between infected and vaccinated animals. Our long-term goal is to develop an efficient acellular paratuberculosis vaccine based on Mpt protein antigen(s) compatible with diagnostic tests. To achieve this goal it is necessary to analyze and characterize secreted and cellular proteins candidate for such a vaccine. Representative Mpt libraries (shuttle plasmid and phage) were constructed and used to study Mpt genes and gene products described below and will be made available to other research groups. In addition, two approaches were performed which did not yield the expected results. Mav or Mpt DNA genes that confer upon Msg or E. coli the ability to invade and/or survive within HEp-2 cells were not identified. Likewise, we were unable to characterize the 34-39 kDa induced secreted proteins induced by stress factors due to technical difficulties inherent to the complexity of the media needed to support substantial M. pt growth. We identified, isolated, sequenced five Mpt proteins and expressed four of them as recombinant proteins that allowed the study of their immunological properties in sensitized mice. The AphC protein, found to be up regulated by low iron environment, and the SOD protein are both involved in protecting mycobacteria against damage and killing by reactive oxygen (Sod) and nitrogen (AhpC) intermediates, the main bactericidal mechanisms of phagocytic cells. SOD and L7/L12 ribosomal proteins are structural proteins constitutively expressed. 85B and CFP20 are both secreted proteins. SOD, L7/L12, 85B and CFP20 were shown to induce a Th1 response in immunized mice whereas AphC was shown by others to have a similar activity. These proteins did not interfere with the DTH reaction of naturally infected cows. Cellular immunity provides protection in mycobacterial infections, therefore molecules inducing cellular immunity and preferentially a Th1 pathway will be the best candidate for the development of an acellular vaccine. The proteins characterized in this grant that induce a cell-mediated immunity and seem compatible with diagnostic tests, are good candidates for the construction of a future acellular vaccine.
APA, Harvard, Vancouver, ISO, and other styles
8

Bercovier, Herve, Michael Collins, Aliza Cohen, and Louis Levy. Recognition and Production of Specific Antigens of Mycobacterium Paratuberculosis. United States Department of Agriculture, October 1992. http://dx.doi.org/10.32747/1992.7600056.bard.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mederos Cuervo, Lilian Maria, Orestes Blanco González, Gilberto Fleites González, Miguel Angel Acosta Suárez, and Osvaldo Castro. Enfermedad diseminada por Mycobacterium avium-intracellulare con escrofulosis inguinal bilateral. Buenos Aires: siicsalud.com, October 2013. http://dx.doi.org/10.21840/siic/137737.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Orme, I. M. Early Diagnosis and Treatment of Opportunistic Mycobacterial Infections in HIV-Seropositive AIDS Patients. Fort Belvoir, VA: Defense Technical Information Center, August 1990. http://dx.doi.org/10.21236/ada227796.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Mycobacteria' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography